【正文】 logic changes in diffuse coronary atherosclerosis [J]. Angiology, 2003, 54(1): 8184.5. Boisvert WA, Rose DM, Boullier A, et al. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size [J]. Arterioscler Thromb Vasc Biol, 2006, 26(3):563569.6. Schrijvers DM, De Meyer GR, Herman AG, et al. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability [J]. Cardiovasc Res, 2007, 73(3): 470480.7. Tabas I. Signal transduction pathways in free cholesterolloaded macrophages: cell biological insight into the progression of atherosclerosis [J]. International Congress Series , 2004, 1 262: 392395.．王雙．動脈粥樣硬化中巨噬細胞凋亡的后果和在治療上的意義：病變階段和吞噬效率的重要性[J]． 中國動脈硬化雜志．2005，13(6)：713.9. Trostdorf F, Buchkremer M, Harmjanz A, et al. Fibrous cap thickness and smooth muscle cell apoptosis in highgrade carotid artery stenosis [J]. Eur J Vasc Endovasc Surg, 2005, 29(5):528535.10. Kirti R, Agrawal DK. Cytokins and growth factors invovlesd in apoptosis and proliferation of vascular smooth muscle cells [J]. International Immunoharmacology, 2005, 5(10): 1 487506.11. Salvayre R, Auge N, Benoist H, et al. Oxidized lowdensitu lipoprotein in monocytic cells [J]. Biochim Biophys Acta, 2002, 1 585(23): 213221. S. Ravichandran，F(xiàn)indme and eatme signals in apoptotic cellclearance: progress and conundrums，The Journal of Experimental Medicine,2010,207(9):18071817.13. Michael R. Elliott, Faraaz B. Chekeni, Paul C. Trampont, Eduardo R. Lazarowski, Alexandra Kadl, Scott F. Walk, Daeho Park, Robin I. Woodson, Marina Ostankovich, Poonam Sharma, Jeffrey J. Lysiak,T. Kendall Harden, Norbert Leitinger amp。 Kodi S. Ravichandran， Nucleotides released by apoptotic cells act as a findme signal to promote phagocytic clearance[J]. Nature,2009,461:282287.14. Misik V , Riesz P. Free radical intermediates in sonodynamic therapy [J] . Annals of the New York Academy of Sciences , 2000 ,899 : 335348. L,Sostaric JZ,Piesz therapya review of the synergistic effects of drugs and ultrasound[J]. Ultrason. Sonochem.,2004,11:349363. T, Kijima M, Yokoyama R, Shindo J, Nagata K, Hirosaka A, Techigawara M, Abe Y, Sato E, Yamaguchi N, Watanabe N, Saito T, Maehara K, Ohmoto Y, Maruyama Y. Expression of cytokine and adhesion molecule mRNA in atherectomy specimens from patients with coronary arery disease. Jpn Circ J. 1999, 63(4):249254.,郭坤元. 光動力治療藥物5 . 2008。24(12):2035. S ,Yumita N ,Nishigaki R ,et al. Sonochemical activation of hematoporphyrin : a potential modility for cancer treatment . Proc of 1989 IEEE Ultrasonic Symp ,9552960. Arakawa, MD。 Kousukue Hagisawa, MD。 Hiroyuki Kusano, MD。 Satoru Yoneyama, MD。 Akira Kurita, MD。 Tsunenori Arai, PhD。 Makoto Kikuchi, PhD。 Isao Sakata, PhD。 Shinichirou Umenura, PhD。 Fumitaka Ohsuzu, MD. Sonodynamic Therapy Decreased Neointimal HyperplasiaAfter Stenting in the Rabbit Iliac . 2002。105:149151. VS , Parilak LD, Kerensky RA. Angiographic paterns and the natural history of the vulnerable plaque. Prog Cardiovasc Dis. 2002。 44 (5):339347. R, Burke AP, Farb A, Kolodgie FD. Pathology of the unstable plaque. Prog Cardiovasc Dis. 2002。 44(5):349356. S, Ishibashi F, Muller JE. Detection and Treatment of Vulnerable Plaques and Vulnerable Patients. Circulation. 2006。 114(22):23902411. death and defective inflammation resolution in atherosclerosis. ，10：3646.25